Ryan Specialty Holdings, Inc.
Ryan Specialty Holdings, Inc. (RYAN) Financial Performance & Income Statement Overview
Explore the financials of Ryan Specialty Holdings, Inc. (RYAN), including yearly and quarterly data on income, cash flow, and balance sheets.
Ryan Specialty Holdings, Inc. (RYAN) Income Statement & Financial Overview
View the income breakdown for Ryan Specialty Holdings, Inc. RYAN across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $690.17M | $663.53M | $604.69M | $701.95M |
| Cost of Revenue | $0.00 | $410.25M | $393.25M | $406.20M |
| Gross Profit | $690.17M | $253.28M | $211.44M | $295.75M |
| Gross Profit Ratio | $1.00 | $0.38 | $0.35 | $0.42 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $536.35M | $104.53M | $88.68M | $497.02M |
| Operating Expenses | $639.13M | $594.49M | $129.97M | $121.39M |
| Total Costs & Expenses | $639.13M | $594.49M | $523.22M | $494.66M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $54.51M | $48.53M | $49.39M | $31.13M |
| Depreciation & Amortization | $67.62M | $63.10M | $41.65M | $32.81M |
| EBITDA | $173.17M | $180.67M | $81.48M | $210.26M |
| EBITDA Ratio | $0.25 | $0.27 | $0.13 | $0.30 |
| Operating Income | $51.04M | $109.32M | $81.48M | $207.28M |
| Operating Income Ratio | $0.07 | $0.16 | $0.13 | $0.30 |
| Other Income/Expenses (Net) | $0.00 | -$40.28M | -$61.80M | -$27.64M |
| Income Before Tax | $51.04M | $69.04M | $19.68M | $136.73M |
| Income Before Tax Ratio | $0.07 | $0.10 | $0.03 | $0.19 |
| Income Tax Expense | $55.43M | $26.49M | -$8.96M | $18.69M |
| Net Income | -$27.64M | $13.75M | $17.59M | $46.79M |
| Net Income Ratio | -$0.04 | $0.02 | $0.03 | $0.07 |
| EPS | -$0.22 | $0.35 | $0.21 | $0.38 |
| Diluted EPS | -$0.22 | $0.05 | $0.09 | $0.37 |
| Weighted Avg Shares Outstanding | $126.03M | $125.41M | $121.92M | $118.39M |
| Weighted Avg Shares Outstanding (Diluted) | $126.03M | $1.33B | $272.69M | $271.22M |
Financial performance has remained strong, with revenue growing from $701.95M in Q2 2024 to $690.17M in Q1 2025. Gross profit continued to perform well, with margins at 100% in the latest quarter. Operating income reached $51.04M in Q1 2025, holding a steady 7% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $173.17M. Net income dropped to -$27.64M, keeping EPS at -$0.22. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan